Goodwin Advises ARTBIO in $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies
July 29, 2025
July 29, 2025
BOSTON, Massachusetts, July 29 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:
* * *
Goodwin Advises ARTBIO in $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies
*
The Life Sciences team advised ARTBIO in the closing of a $132 million Series B financing co-led by new investors Sofinnova Investments and B Capital along with a life sciences dedicated investment fund that invested . . .
* * *
Goodwin Advises ARTBIO in $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies
*
The Life Sciences team advised ARTBIO in the closing of a $132 million Series B financing co-led by new investors Sofinnova Investments and B Capital along with a life sciences dedicated investment fund that invested . . .